上腺素载体的基质结合和抑制机制
Wenming Ji1, Anran Miao1, Kai Liang1
1State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.
使用冷EM揭示了人类上腺素输送器 (hNET) 的结构洞察力. 这些发现澄清了hNET如何与基质和抑制剂结合,这对于理解神经疾病至关重要.
科学领域:
- 神经科学
- 结构生物学
- 生物化学
背景情况:
- 上腺素转运体 (NET; SLC6A2) 调节突触上腺素水平,影响神经功能.
- 网络功能障碍与各种神经疾病有关,使其成为关键的治疗点.
- NET的精确结构和传输机制在很大程度上是未知的.
研究的目的:
- 阐明人类NET (hNET) 功能的结构基础.
- 了解hNET的基质识别和正经抑制机制.
- 为开发新型NET向疗法提供结构基础.
主要方法:
- 使用冷电子显微镜 (cryo-EM) 来确定hNET的高分辨率结构.
- 在三个不同的功能状态下捕获结构:apo,基质结合 (MIBG) 和抑制剂结合 (radafaxine).
- 分析的重点是hNET内部的构造变化,关机制和联体结合相互作用.
主要成果:
- 解决了hNET的内向构造,具有密封的细胞外和开放的细胞内门.
- 观察到基质甲基胺 (MIBG) 与hNET的中心部位结合.
- 抑制剂拉达法辛与基质结合部位结合,可能阻碍运输所需的形状转换.
结论:
- 确定的hNET结构为其传输机制提供了前所未有的洞察力.
- 在结构层面上理解基质和抑制剂的结合,有助于设计针对性的神经疗法.
- 这些发现为未来的NET监管和药理研究铺平了道路.
更多相关视频
08:33Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time
Published on: March 11, 2021
10:24NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
Published on: June 30, 2019
相关概念视频
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Affecting Neurotransmitter Synthesis
Enzyme Inhibition
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Neurochemical Transmission: Sites of Drug Action
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which...
